Sumitomo Chemical India AGM to approve leadership transition
Sumitomo Chemical India Limited has convened its Twenty-Sixth Annual General Meeting for 27 July 2026 via Video Conferencing to approve a leadership transition, including the promotion of Dr Suresh Ramachandran to Managing Director and the appointment of Mr Chetan Shah as Non-Executive Non-Independent Director. The agenda includes the declaration of a ₹1.30 per share dividend with a record date of 17 July 2026 and the approval of related party transactions aggregating ₹16,235 million with its holding company. Additionally, the meeting covers the reappointment of Independent Directors and the ratification of Cost Auditor remuneration.

*this image is generated using AI for illustrative purposes only.
Sumitomo Chemical India Limited has scheduled its Twenty-Sixth Annual General Meeting for Monday, 27 July 2026, at 02:30 P.M. via Video Conferencing. The meeting seeks shareholder approval for a significant leadership transition, with Dr Suresh Ramachandran, currently Deputy Managing Director, proposed to be promoted to Managing Director effective 1 September 2026. Concurrently, Mr Chetan Shah, the outgoing Managing Director, is proposed to be appointed as Non-Executive Non-Independent Director from the same date. Shareholders will also consider the reappointment of Mr N Sivaraman and the appointment of Mr Anand Mohan Tiwari as Independent Directors.
Leadership and Board Changes
Dr Suresh Ramachandran’s promotion to Managing Director is subject to the approval of a special resolution, with his tenure extending until 31 May 2028. His annual gross salary is set at ₹28,066,500. Mr Chetan Shah will transition to the role of Non-Executive Non-Independent Director and Advisor, with the Board approving remuneration not exceeding ₹30 million for the period from September 2026 to August 2027. The Board also proposes the reappointment of Mr N Sivaraman as Independent Director for a three-year term ending 31 August 2029, and the appointment of Mr Anand Mohan Tiwari as Independent Director for a two-year term ending 30 August 2028.
Dividend and Related Party Transactions
The Board has recommended a dividend of ₹1.30 per equity share for the financial year ended 31 March 2026. The record date for determining eligibility has been fixed as Friday, 17 July 2026, with payment scheduled on or after Monday, 3 August 2026. Additionally, shareholders will vote on approving related party transactions with holding company Sumitomo Chemical Company, Limited, Japan. The aggregate value of these transactions for FY 2026-27 is estimated at ₹16,235 million, representing 50.59% of the Company's consolidated turnover for FY 2025-26.
Key AGM Details
| Agenda Item | Details |
|---|---|
| Date & Time | Monday, 27 July 2026 at 02:30 P.M. |
| Mode | Video Conferencing (VC) / OAVM |
| Dividend Record Date | Friday, 17 July 2026 |
| Dividend Payment Date | On or after Monday, 3 August 2026 |
| Remote E-voting | 23 July 2026 (09:00 A.M.) to 26 July 2026 (05:00 P.M.) |
| Cost Auditor Remuneration | ₹550,000 plus taxes for FY 2026-27 |
The meeting also includes the ratification of the remuneration of Cost Auditors M/s GMVP & Associates LLP. The remote e-voting period commences on 23 July 2026 and concludes on 26 July 2026.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE258G01013/bb9235a030674b93.pdf
Historical Stock Returns for Sumitomo Chemical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.00% | -3.72% | +20.02% | +24.26% | -11.53% | +21.57% |
What strategic shifts can investors expect under Dr. Suresh Ramachandran's leadership compared to the outgoing administration?
How will the company work to reduce its reliance on related party transactions with the Japanese holding company, which currently exceed 50% of turnover?
What is the rationale behind the significant increase in remuneration for the incoming Managing Director compared to the current leadership structure?


































